Episode Details

Back to Episodes
Episode 133: ESMO 2021: Cabozantinib and atezolizumab in prostate cancer

Episode 133: ESMO 2021: Cabozantinib and atezolizumab in prostate cancer

Season 1 Episode 136 Published 5 years, 1 month ago
Description

Neeraj Agarwal describes the phase 2 study and the phase 3 plans. 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us